Skip to main content

The Role of Digital Health Technologies in Drug Development Proceedings of a Workshop (2020) / Chapter Skim
Currently Skimming:

1 Introduction
Pages 1-4

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 1...
... DHTs range from hardware -- such as wearable devices and sensors -- to software, such as mobile phone apps that enable consumers to monitor their own health and participate in studies; telemedicine platforms to connect patients with clinical providers; and artificial intelligence to support clinical decision making. DHTs offer new modalities for capturing personal and sensitive health data from patients as they carry on with their daily lives (CTTI, 2019)
Read the entire page →
From page 2...
... Over time, DHTs may help transform current drug development and clinical trial paradigms. For example, DHTs can be used to enable continuous data collection, provide surrogate endpoints for efficacy, support participant engagement to improve adherence and retention, and broaden access to and increase representation of clinical research.
Read the entire page →
From page 3...
... , the virus that causes coronavirus disease 2019 (COVID-19) , was spreading around 2 The workshop Statement of Task, workshop agenda, planning committee biographical sketches, and speaker biographical sketches can be found in Appendixes A, B, C, and D, respectively.
Read the entire page →
From page 4...
... Chapter 6 describes the role that DHTs can play in supporting post-market surveillance, comparative effectiveness research, and patient centricity. Chapter 7 features reflections on the workshop and key takeaways highlighted by the workshop's co-chairs, Jennifer Goldsack, executive director of the Digital Medicine Society, and Joseph Menetski, associate vice president of Research Partnerships and director of the Biomarkers Consortium at the Foundation for the National Institutes of Health.
Read the entire page →

Key Terms

  • digital health
  • clinical trials
  • development lifecycle
  • health technologies
  • clinical care

  • clinical providers
  • precision medicine
  • patient care
  • participants considered
  • safety trials

  • virtual clinical
  • drug discovery
  • health measures
  • clinical decision
  • workshop builds

  • own health
  • ized clinical
  • digital medicine
  • drug candidates
  • current drug

  • support drug
  • workshop comprised
  • clinical trial
  • broader patient
  • patient centricity

  • precision health
  • clinical validity
  • workshop statement
  • improving precision
  • workshop featured


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.